Withdrawal of Parathyroid Hormone Treatment Causes Rapid Resorption of Newly Formed Vertebral Cancellous and Endocortical Bone in Old Rats
- 1 July 1998
- Vol. 23 (1) , 43-52
- https://doi.org/10.1016/s8756-3282(98)00072-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The influence of growth hormone on cancellous and cortical bone of the vertebral body in aged ratsJournal of Bone and Mineral Research, 1996
- Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized ratsJournal of Bone and Mineral Research, 1996
- Parathyroid hormone (1–34) increases vertebral bone mass, compressive strength, and quality in old ratsBone, 1995
- Growth hormone stimulates bone formation and strength of cortical bone in aged ratsJournal of Bone and Mineral Research, 1995
- Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized ratsJournal of Bone and Mineral Research, 1995
- PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)—assessed in sexually mature, ovariectomized ratsBone, 1994
- The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized ratsEndocrinology, 1994
- Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical propertiesCalcified Tissue International, 1993
- Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized ratsCalcified Tissue International, 1993
- Ectopic Bone Formation and AgingPublished by Wolters Kluwer Health ,1981